openPR Logo
Press release

Pulmonary Needles Market Expansion Projected to Gain an Uptick During 2018 to 2028

11-22-2018 03:49 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Fact.MR

Pulmonary Needles Market Expansion Projected to Gain an Uptick

A pulmonary needle is a hollow hypodermic needle designed for insertion into the lungs. Pulmonary needles are used for diagnosis, prognosis or treatment of lung disorders, such as cancer, and infective diseases, such as tuberculosis, abscess, sepsis, viral and bacterial infection and others. Biopsy and aspiration are the major procedures that account for the major use of pulmonary needles. Manual loading is being increasingly replaced by automatic, spring-loaded mechanisms or vacuum-assisted devices (VADs).

Request Report Sample @ https://www.factmr.com/connectus/sample?flag=S&rep_id=1171

Pulmonary Needles Market: Drivers and Restraints

Increase in the number of various procedures, such as fine needle aspiration and biopsies, owing to the growing prevalence of lung diseases, such as infections, bronchitis and cancer, due to growing risk factors, such as smoking, exposure to allergens and carcinogens and others, is the prime driver for the pulmonary needles market. The American Cancer Society’s estimates about 234,030 new cases of lung cancer and about 154,050 deaths in 2018.

The primary technological driver for the pulmonary needles market is the rapid adoption of diagnostics, such as computed tomography (CT), fluoroscopy and ultrasound, which provide critical benefits, such as direct real time imaging and improved success rate by a large margin. Advancements in materials, such as the substitution of stainless steel by cobalt chromium, which is 24% harder, helps to maintain tip sharpness and is more resilient to deformation over multiple passes, will further add to the growth of the pulmonary needles market. Innovations in design represent the largest market opportunity as market position is of critical importance in the industry. Innovative designs, such as ergonomic rotating handle and slip resistant grip, for better needle control and precision, are gaining a large traction. The restraints in the pulmonary needles market are the various risks, such as chest pain, nosocomial infection, difficulty in breathing, fever or swelling and bleeding from the site.

View Full Report @ https://www.factmr.com/report/1171/pulmonary-npulmonary-needles-market

Pulmonary Needles Market: Segmentation

To gain a bird’s eye view and a better understanding of the future market equity, the pulmonary needles report is segmented based on clinical indication, loading mechanism, end user and region.

Based on clinical indications, the global pulmonary needles market is divided into the following:

Tumor
Malignancy
Non-Malignant
Infectious Diseases
Cardiovascular
Inflammation
Others

Based on loading mechanism, the global pulmonary needles market is divided into the following:

Manual
Spring loading
Others

Based on end user, the global pulmonary needles market is segmented as below:

Hospitals
Ambulatory Surgical Centers
Others

Pulmonary Needles Market: Overview

The global market for pulmonary needles is consolidated with a few large players dominating the scene. The market trends include combined approaches of using pulmonary needles with acoustic imaging to obtain accurate diagnosis and prognosis of conditions, which is expected to create high market demand. Some of the established brands of pulmonary needles are Veran Medical Technologies, Cook Medical, Veran Medical Technologies, Bostonscientific, argonmedical, BreStem Therapeutics, SOMATEX Medical Technologies GmbH, Medi-Globe GmbH and others.

Pulmonary needles Market: Regional Wise Outlook

The global pulmonary needles market is classified into North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan and Middle East and Africa. North America is expected to account for the largest share in the global pulmonary needles market owing to the high concentration of key market players, excellent reimbursement rate and large healthcare expenditure amounting to 16% of GDP in 2016. The approval of Medicare & Medicaid Services (CMS) for Screening of Lung Cancer is expected to further drive large market adoption.

Ask an Analyst @ https://www.factmr.com/connectus/sample?flag=AE&rep_id=1171

The Asia Pacific market excluding Japan is expected to grow at a significant CAGR owing to the expansion of healthcare and growing prosperity in the country. China and India are expected to hold the lion’s share in the market. Europe, led by Germany, France and the UK, is expected to make the second largest market. The Middle East and Africa pulmonary needles market is expected to incline towards gulf economies, such as Saudi Arabia, Kuwait and Qatar.

Pulmonary needles Market: Key Players

Some of the major players in the global pulmonary needles market are Veran Medical Technologies, Cook Medical, Veran Medical Technologies, Boston scientific, argonmedical, BreStem Therapeutics, SOMATEX Medical Technologies GmbH, Medi-Globe GmbH and others.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Request TOC of this Report @ https://www.factmr.com/connectus/sample?flag=T&rep_id=1171

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact us

Fact.MR

353-1-6111-593

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

Email: sales@factmr.com

Web: https://www.factmr.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pulmonary Needles Market Expansion Projected to Gain an Uptick During 2018 to 2028 here

News-ID: 1392986 • Views:

More Releases from Fact.MR

Intelligent Transport System Market is Evaluatedto Reach USD 63.77 Billion by 2034 | Fact.MR
Intelligent Transport System Market is Evaluatedto Reach USD 63.77 Billion by 20 …
Fact.MR today released its latest report on the Intelligent Transport System (ITS) Market, projecting robust growth driven by increasing urbanization, rising demand for efficient traffic management, and advancements in smart mobility technologies. Valued at USD 30.66 billion in 2024, the global market is forecasted to expand at a compound annual growth rate (CAGR) of 7.6%, reaching USD 63.77 billion by 2034. This significant growth underscores the critical role of ITS
Digital Door Lock System Market is Growing at a CAGR of 16% by 2034 | Key Players: Honeywell International Inc., Godrej & Boyce Manufacturing Company Ltd., and Samsung Electronics Co Ltd
Digital Door Lock System Market is Growing at a CAGR of 16% by 2034 | Key Player …
Digital Door Lock System Market is valued at USD 11 billion in 2024 and is projected to expand at a compound annual growth rate (CAGR) of 16%, reaching USD 48.7 billion by 2034. This remarkable growth is driven by the increasing popularity of smart homes, which integrate advanced security features for enhanced convenience and protection. Digital door lock systems, utilizing technologies like biometrics and wireless connectivity, offer keyless entry, remote
Electronic Access Control Systems Market is Estmated to Reach USD 32.5 Billion by 2033 | Key Players: Cisco Systems, Siemens AG, Honeywell International Inc., Robert Bosch GmbH, Schneider Electric SE
Electronic Access Control Systems Market is Estmated to Reach USD 32.5 Billion b …
The global electronic access control systems market is valued at USD 14.64 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 8.3%, reaching USD 32.5 billion by 2033. This growth is driven by the increasing need for advanced security solutions amid rising threats of terrorism, break-ins, and data breaches. Electronic access control systems, encompassing biometrics, card-based, keypad, intruder alarm, and perimeter security technologies,
Neurology Devices Market is Estimated to Reach USD 22,335.5 Million by 2035 | Fact.MR Report
09-01-2025 | Health & Medicine
Fact.MR
Neurology Devices Market is Estimated to Reach USD 22,335.5 Million by 2035 | Fa …
Neurology Devices Market was valued at USD 10,944.3 million in 2024 and is forecasted to expand at a CAGR of 6.7%, reaching USD 22,335.5 million by 2035. This growth reflects the increasing demand for advanced diagnostic and therapeutic tools to address neurological disorders, including Alzheimer's disease, Parkinson's disease, major depression, epilepsy, spinal cord injury, and traumatic brain injury. Neurology devices play a crucial role in diagnosing, preventing, and treating these

All 5 Releases


More Releases for Pulmonary

Chronic Pulmonary Aspergillosis Drugs Market - Revitalizing Lungs: Revolutionary …
Newark, New Castle, USA - new report, titled Chronic Pulmonary Aspergillosis Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Chronic Pulmonary Aspergillosis Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Chronic Pulmonary Aspergillosis Drugs market. The report offers
Global Pulmonary Embolism Market Size & Trends
According to a new market research report published by Global Market Estimates, the Global Pulmonary Embolism Market is exhibited at USD 1.59 billion in 2023 and is projected to surpass USD 3.15 billion in 2028, anticipated to grow at a CAGR of 8.4% from 2023 to 2028. The rapid increase in the prevalence of cancer, increasing investment for healthcare infrastructure and rising research and development activities, high disposable income, rising demand
Global Pulmonary Arterial Hypertension Market Size
According to a new market research report published by Global Market Estimates, the Global Pulmonary Arterial Hypertension Market is projected to grow at a CAGR of 5.2% from 2022 to 2027. Congenital heart diseases and other ailments such as HIV infection, chronic liver disease (cirrhosis), and connective tissue disorders (scleroderma, lupus, and others) are fueling market expansion. Browse 153 Market Data Tables and 113 Figures spread through 185 Pages and in-depth TOC
New Study: Pulmonary Drugs Market Report
The pulmonary drugs market is expected to witness unprecedented growth in the near future, thanks to large number of approvals from the FDA. The FDA approved a large number of pulmonary drugs for major illnesses like small-cell lung cancer, tuberculosis, and pneumonia over the past few years. Additionally, newly approved drugs also treat newly found diseases like obstructive sleep apnea. These approvals are in line with the recent trend of
Pulmonary Drugs Market Forecast till 2025
Pulmonary Drugs Market – Boon for Diseased Lungs Pulmonary drugs can treat wide range of conditions, which are included within the ambit of pulmonary diseases such as pneumonia, allergic rhinitis, pulmonary hypertension, and others. . Pulmonary drugs provide medications for all types of pulmonary diseases, which is expected to fuel market growth in near future. The World Health Organization (WHO) states that most respiratory diseases are preventable and can be treated
03-15-2017 | Health & Medicine
TMR
Pulmonary Drug Delivery Devices Market: Demand for Pulmonary Drug Delivery Devic …
This report on pulmonary drug delivery devices studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture and commercialization of various pulmonary/respiratory drugs and/or drug-device combinations as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments